Literature DB >> 12679420

Histidine decarboxylase, a pyridoxal phosphate-dependent enzyme, is an autoantigen of gastric enterochromaffin-like cells.

Filip Sköldberg1, Guida M Portela-Gomes, Lars Grimelius, Gunnar Nilsson, Jaakko Perheentupa, Corrado Betterle, Eystein S Husebye, Jan Gustafsson, Anders Rönnblom, Fredrik Rorsman, Olle Kämpe.   

Abstract

Patients with autoimmune polyendocrine syndrome type 1 often have autoantibodies against neurotransmitter synthesizing enzymes, including the pyridoxal phosphate-dependent enzymes glutamic acid decarboxylase and aromatic L-amino acid decarboxylase. Using a candidate approach, we have identified the histamine-synthesizing enzyme histidine decarboxylase, also pyridoxal phosphate dependent, as an autoantigen in this disorder. Anti-histidine decarboxylase antibodies reacting with in vitro translated antigen were found in 36/97 (37%) of autoimmune polyendocrine syndrome type 1 patients studied. The antibodies also reacted with the native enzyme in HMC-1 cell lysates and did not cross-react with the highly homologous aromatic L-amino acid decarboxylase. Anti-histidine decarboxylase antibodies were associated with a history of intestinal dysfunction (P = 0.017). Gastric and duodenal biopsies from a patient with anti-histidine decarboxylase antibodies were studied by immunohistochemistry. The oxyntic mucosa was found to lack the histamine producing enterochromaffin-like cells, suggestive of an autoimmune destruction. To our knowledge, this is the first report of autoantibodies against histidine decarboxylase and absence of gastric enterochromaffin-like cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679420     DOI: 10.1210/jc.2002-021761

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity.

Authors:  P Peterson; J Pitkänen; N Sillanpää; K Krohn
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 2.  Lessons from primary immunodeficiencies: Autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Gregory M Constantine; Michail S Lionakis
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 3.  Polyendocrine autoimmunity.

Authors:  Jennifer M Barker
Journal:  Curr Diab Rep       Date:  2005-04       Impact factor: 4.810

Review 4.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy.

Authors:  Kai Kisand; Pärt Peterson
Journal:  J Clin Immunol       Date:  2015-07-05       Impact factor: 8.317

Review 5.  Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy from the pediatric perspective.

Authors:  D Capalbo; N Improda; A Esposito; L De Martino; F Barbieri; C Betterle; C Pignata; M Salerno
Journal:  J Endocrinol Invest       Date:  2013-05-30       Impact factor: 4.256

Review 6.  Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED.

Authors:  D Moraes-Vasconcelos; B T Costa-Carvalho; T R Torgerson; H D Ochs
Journal:  J Clin Immunol       Date:  2008-02-09       Impact factor: 8.317

7.  Case Report: Severe Hypocalcemic Episodes Due to Autoimmune Enteropathy.

Authors:  Inbal Halabi; Marie Noufi Barohom; Sarit Peleg; Phillippe Trougouboff; Ghadir Elias-Assad; Rhania Agbaria; Yardena Tenenbaum-Rakover
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-14       Impact factor: 5.555

8.  APECED: is this a model for failure of T cell and B cell tolerance?

Authors:  Nicolas Kluger; Annamari Ranki; Kai Krohn
Journal:  Front Immunol       Date:  2012-08-02       Impact factor: 7.561

9.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: insights into genotype-phenotype correlation.

Authors:  Donatella Capalbo; Lucia De Martino; Giuliana Giardino; Raffaella Di Mase; Iolanda Di Donato; Giancarlo Parenti; Pietro Vajro; Claudio Pignata; Mariacarolina Salerno
Journal:  Int J Endocrinol       Date:  2012-10-22       Impact factor: 3.257

10.  Pyridoxal phosphatase is a novel cancer autoantigen in the central nervous system.

Authors:  A S Bøe; G Bredholt; P M Knappskog; A Storstein; C A Vedeler; E S Husebye
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.